ALK‐1

:   anaplastic lymphoma kinase‐1

BA

:   bronchiolar adenoma

*BRAF*

:   v‐raf murine sarcoma viral oncogene homolog B1

CDX‐2

:   caudal‐type homeobox‐2

CK

:   cytokeratin

CMPT

:   ciliated muconodular papillary tumor

EGFR

:   epidermal growth factor receptor

HPV

:   human papillomavirus

ISH

:   *in situ* hybridization

*KRAS*

:   *Kirsten RAS*

MUC

:   mucin

*NRAS*

:   *neuroblastoma RAS*

NSCLC

:   non‐small cell lung carcinoma

OIS

:   oncogene‐induced senescence

p16^INK4a^

:   cyclin‐dependent kinase inhibitor p16

TTF‐1

:   thyroid transcription factor‐1

INTRODUCTION {#pin12904-sec-0010}
============

Bronchiolar adenoma (BA) of the lung is a newly recognized rare peripheral lung tumor histologically characterized by nodular proliferation of bilayered benign‐looking bronchiolar‐type epithelium with a continuous layer of basal cells. BA was first reported as ciliated muconodular papillary tumor (CMPT) in 2002 by Ishikawa.[^1^](#pin12904-bib-0001){ref-type="ref"} The majority of the BA lesions, however, do not fit all of the diagnostic criteria of CMPT; BA often exhibits only focal or no papillary architecture, and contains variable numbers of ciliated and mucinous cells, with some lesions entirely lacking one or both of these components.[^2^](#pin12904-bib-0002){ref-type="ref"}, [^3^](#pin12904-bib-0003){ref-type="ref"} The morphologic and immunohistochemical features resemble proximal bronchioles (32%) or respiratory bronchioles (68%). The proximal‐type is characterized by moderate to abundant mucinous and ciliated cells with negative or weak thyroid transcription factor‐1 (TTF‐1), while the distal‐type reveals scanty or absent mucinous and ciliated cells with positivity of TTF‐1.[^2^](#pin12904-bib-0002){ref-type="ref"}

We report herein a surgical case of distal‐type BA expressing cyclin‐dependent kinase inhibitor p16 (p16^INK4a^), with demonstration of ultrastructural features and review of the literature.

CLINICAL SUMMARY {#pin12904-sec-0020}
================

A 77‐year‐old Japanese female nonsmoker was referred to Shimada Municipal Hospital because of a chest abnormal shadow on the chest X‐ray in routine health checkup. Four years earlier, she had suffered from breast cancer without recurrence. Chest computed tomography revealed an 8 mm solitary ground glass nodule without cavitation or pleural retraction in the peripheral field of the right lower lobe of the lung, and the tumor was penetrated by a peripheral bronchiolo‐arterial bundle (Fig. [1](#pin12904-fig-0001){ref-type="fig"}). No radiological and clinical features of interstitial lung disease were recognized. Neither lymphadenopathy nor metastatic lesions were noted. During the follow‐up for 7 months, the lesion showed no size change. Primary lung cancer was suspected with a differential diagnosis of metastatic mammary carcinoma, and she was admitted for surgical intervention. The intraoperative frozen section diagnosis was adenocarcinoma, mimicking adenocarcinoma *in situ*, invasive mucinous adenocarcinoma or minimally invasive adenocarcinoma. Video‐assisted thoracoscopic wedge resection of the lung tumor was performed. The patient did not receive adjuvant therapy, and is currently doing well, 6 months after surgery.

![Clinical imaging. (**a**) A chest computed tomography image reveals an 8 mm solitary groundglassed nodule in the peripheral field of the right lower lung lobe. (**b**) The tumor, illustrated in purple color, is penetrated by a peripheral bronchiolo‐arterial bundle.](PIN-70-179-g001){#pin12904-fig-0001}

PATHOLOGICAL FINDINGS {#pin12904-sec-0030}
=====================

Gross morphology {#pin12904-sec-0040}
----------------

Grossly, the lesion displayed a localized, 8 × 4 × 3 mm‐sized and whitish tumor with gelatinous quality. No pleural retraction was observed. The resected margins were negative for tumor tissue.

Microscopic findings {#pin12904-sec-0050}
--------------------

The microscopically ill‐defined nodular lesion showed a lepidic growth pattern, conforming to the preexisting pulmonary architecture (Fig. [2a](#pin12904-fig-0002){ref-type="fig"}). Bronchiolar epithelia grew with inflammatory stroma, and their cytoplasm contained gastric foveolar‐ or glandular‐like mucin (Fig. [2b](#pin12904-fig-0002){ref-type="fig"}). Papillary architecture was unremarkable. Close microscopic observation demonstrated a bilayered pattern of growth: basal cells surrounded luminal columnar cells (Fig. [2c](#pin12904-fig-0002){ref-type="fig"}). Ciliated cells were focally identified (Fig. [2d](#pin12904-fig-0002){ref-type="fig"}). Elastic fiber staining demonstrated focal loss or disruption of alveolar elastic framework (Fig. [2e](#pin12904-fig-0002){ref-type="fig"}). The tumor cells lacked nuclear atypia and mitotic figures. The alveoli located at the periphery of the lesion were filled with alcianophilic mucin (Fig. [2f](#pin12904-fig-0002){ref-type="fig"}).

![Microscopic findings of the lung tumor. (**a**) The lung parenchyma contains a defined nodular lesion with lepidic glandular growth and mucin secretion (HE). (**b**) Bronchiolar epithelia grow with inflammatory stroma, and gastric foveolar or glandular‐like mucin is observed in the cytoplasm (HE). (**c**) High‐powered view reveals a bilayered pattern of growth: basal cells surround the luminal columnar cells (HE). (**d**) A few ciliated cells are distributed (arrow) (HE). (**e**) Elastica van Gieson stain demonstrates focal loss or disruption of the alveolar elastic framework. (**f**) The alveoli at the periphery of the tumor are filled with alcianophilic mucin (Alcian blue, pH 2.5).](PIN-70-179-g002){#pin12904-fig-0002}

Immunohistochemistry {#pin12904-sec-0060}
--------------------

As indicated in Fig. [3](#pin12904-fig-0003){ref-type="fig"}, the ciliated, mucous and basal cells expressed cytokeratin 7 (CK7), thyroid transcription factor‐1 (TTF‐1: clone 8G7G3/1) and p16^INK4a^ (clone: G175‐405). β‐catenin revealed membranous and cytoplasmic staining. The ciliated columnar and mucous luminal‐sided tumor cells were positive for napsin A, carcinoembryonic antigen and mucin 1 (MUC1). MUC5AC was focally expressed in the cytoplasm of the mucous cells. The basal cells were positive for CK5/6, p40, p63 and podoplanin (clone D2‐40). Ki‐67 labeling index was 3%. Negative markers included CK20, caudal‐related homeobox protein‐2 (CDX2), p53, chromogranin A, synaptophysin, MUC2, MUC6 and hepatocyte nuclear factor‐4α. Anaplastic lymphoma kinase‐1 (ALK‐1) protein was negative (ALK iScore 0), employing the HISTOFINE ALK iAEP kit (Nichirei Bioscience, Tokyo, Japan). Programmed death‐ligand 1 (clone: 22C3) was also negative.

![Immunohistochemical findings of the lung tumor. (**a**) Cytokeratin (CK)7, (**b**) Thyroid transcription factor‐1 (TTF‐1), (**c**) Cyclin‐dependent kinase inhibitor p16 (p16^INK4a^), (**d**) napsin A, (**e**) Mucin (MUC)1, and (**f**) CK5/6 (**a--f**: original magnification ×200). CK7 and TTF‐1 are diffusely positive in both the columnar and basal cells. p16^INK4a^ is partly expressed in both cell types. The columnar cells are immunoreactive for napsin A and MUC1 while the basal cells are negative. CK5/6 clearly decorates the basal cells.](PIN-70-179-g003){#pin12904-fig-0003}

Ultrastructural findings {#pin12904-sec-0070}
------------------------

The bronchiolar epithelial tubules consisted of two layers; the inner nonciliated microvillous cells and outer basal‐like cells. Some (but not all) of the inner cells were filled with mucin granules in the cytoplasm. The cytoplasm of the basal cells was scanty. Ciliated cells were not included in the specimen evaluated. Representative fine structural features are demonstrated in Fig. [4](#pin12904-fig-0004){ref-type="fig"}.

![Electron microscopic findings of the lung tumor. (**a**) The bronchiolar epithelial tubules consist of two layers; the inner non‐ciliated microvillous cells and outer basal‐like cells (bar = 10 μm). (**b**) Some of the inner cells are filled with mucin granules in the cytoplasm (bar = 2 μm). (**c**) The cytoplasm of the basal cells is scanty (bar = 2 μm).](PIN-70-179-g004){#pin12904-fig-0004}

Molecular findings {#pin12904-sec-0080}
------------------

We evaluated gene mutations of v‐raf murine sarcoma viral oncogene homolog B1 (*BRAF*V600E), *Kirsten RAS*, *neuroblastoma RAS* and epidermal growth factor receptor (EGFR: exons 18, 19, 20 and 21). In brief, real‐time polymerase chain reaction (PCR) was applied to the detection of *BRAFV600E* mutations using a fluorescent oligonucleotide probe. PCR‐reverse sequence specific oligonucleotide method was utilized for the *RAS* gene analysis. Mutation analysis of EGFR was performed with real‐time PCR employing scorpion‐amplification refractory mutation system. No mutations were demonstrated. Because of p16^INK4a^ expression, human papillomavirus (HPV) DNA was examined by *in situ* hybridization (ISH) assay employing biotinylated cocktail probes for both high and low risk HPV (Enzo Life Sciences, Farmingdale, NY, USA). HPV genome was not detected in tumor cell nuclei.

DISCUSSION {#pin12904-sec-0090}
==========

Bronchiolar adenoma is an extremely rare lung tumor.[^2^](#pin12904-bib-0002){ref-type="ref"} Ishikawa[^1^](#pin12904-bib-0001){ref-type="ref"} reported the first case in 2002, and named it ciliated muconodular papillary tumor. Literature review indicated a total of 68 cases reported to date.[^1^](#pin12904-bib-0001){ref-type="ref"}, [^2^](#pin12904-bib-0002){ref-type="ref"}, [^3^](#pin12904-bib-0003){ref-type="ref"}, [^4^](#pin12904-bib-0004){ref-type="ref"}, [^5^](#pin12904-bib-0005){ref-type="ref"}, [^6^](#pin12904-bib-0006){ref-type="ref"}, [^7^](#pin12904-bib-0007){ref-type="ref"}, [^8^](#pin12904-bib-0008){ref-type="ref"}, [^9^](#pin12904-bib-0009){ref-type="ref"}, [^10^](#pin12904-bib-0010){ref-type="ref"} The clinicopathological features of the previously reported cases are summarized in Table [1](#pin12904-tbl-0001){ref-type="table"}. The tumor size ranged from 2 to 15 mm. BA was often observed in middle‐aged and elderly individuals (median age, 67 years), while a case of a 19‐year‐old girl was reported in the literature.[^4^](#pin12904-bib-0004){ref-type="ref"} BA occurred in both men and women (M/F = 34:36), with no preference on the location in the lung. BA was histologically featured by bilayered growth of bronchiolar‐type luminal columnar cells and basal cells (CK5/6, p40 and p63‐positive) forming a continuous layer, recapitulating various levels of the bronchiolar tree. Based on morphologic and immunohistochemical features of the respective portions of the bronchiolar tree, Chang *et al*.[^2^](#pin12904-bib-0002){ref-type="ref"} divided BA into proximal and distal types. The present lesion belonged to the distal‐type BA. Neither recurrence nor distant metastasis has been reported during 1‐month to 10‐year follow‐up periods after surgery.

###### 

Summary of the clinical features of previously reported BA cases and the present case

  First author/Publication year                            Age (years)/sex         Location   Size (mm)          CT findings       Treatment                  Outcome (months)
  -------------------------------------------------------- ----------------------- ---------- ------------------ ----------------- -------------------------- ------------------------
  Present case                                             77F                     RLL        8                  GGO               WR                         6 NED
  Ishikawa[^1^](#pin12904-bib-0001){ref-type="ref"} 2002   50F                     RUL        15                 Nodule            Lobectomy                  120 NED
  Harada^3^ 2008                                           62M                     LLL        9                  Nodule            WR                         24 NED
  Sato^3^ 2010                                             67M                     RUL        8                  Nodule with GGO   WR                         10 NED
  Hata^3^ 2013                                             59F                     RLL        5                  GGO with cavity   WR                         18 NED
  Chuang^3^ 2014                                           68M                     RLL        12                 GGO               WR                         48 NED
  Kamata^3^ 2015                                           61M                     RUL        10                 Nodule            WR                         76 NED
                                                           60F                     LLL        15                 Nodule            WR                         33 NED
                                                           78M                     RLL        9                  Nodule            Segmentectomy              66 NED
                                                           63M                     RLL        11                 Nodule            Lobectomy                  63 NED
                                                           75M                     LLL        6                  Nodule            WR                         44 NED
                                                           62F                     LLL        13                 NWC               WR                         45 NED
                                                           57M                     RLL        12                 Nodule            WR                         7 NED
                                                           56M                     RLL        11                 Nodule            WR                         4 NED
                                                           66M                     LLL        7                  Nodule            WR                         88 NED
                                                           61F                     RLL        6                  Nodule            WR                         2 NED
  Ishikawa^3^ 2016                                         66M                     RUL        10                 Nodule            Lobectomy                  58 NED
                                                           82F                     LLL        10                 Nodule            PR                         55 NED
                                                           77M                     LLL        N/A                Nodule            Lobectomy                  48 NED
                                                           70M                     RLL        30                 GGO               PR                         19 NED
                                                           67F                     RLL        5                  Nodule            PR                         28 NED
  Kon^3^ 2016                                              80M                     LLL        7                  Nodule            WR                         29 NED
                                                           67M                     RLL        10                 Nodule            WR                         25 NED
                                                           66M                     RLL        13                 NWC               Lobectomy                  14 NED
                                                           73F                     LUL        9                  NWC               WR                         5 NED
                                                           70F                     RUL        8                  Nodule            WR                         48 NED
  Lau[^4^](#pin12904-bib-0004){ref-type="ref"} 2016        19F                     RLL        13                 Nodule            WR                         N/A
  Liu^3^ 2016                                              60M                     RLL        8                  Nodule            WR                         7 NED
                                                           83F                     RML        4                  Nodule            Lobectomy                  N/A
                                                           81F                     LL         3 to 4             Nodule            WR                         N/A
                                                           71F                     LUL        12                 Nodule            WR                         120 NED
  Chu[^5^](#pin12904-bib-0005){ref-type="ref"} 2017        56M                     LUL        11                 Nodule            WR                         5 NED
  Jin^3^ 2017                                              59F                     RLL        8                  NWC               WR                         6 NED
  Kim[^6^](#pin12904-bib-0006){ref-type="ref"} 2017        73M                     LLL        9                  GGO               WR                         36 NED
  Taguchi^3^ 2017                                          84F                     RLL        8                  Nodule            WR                         10 NED
  Udo^3^ 2017                                              Med: 67 (M:F = 0:4)     N/A        Med: 11            N/A               Lobectomy &segmentectomy   N/A
  Chang[^2^](#pin12904-bib-0002){ref-type="ref"} 2018      Med: 72 (M:F = 11:10)   N/A        Ave: 6 (2 to 11)   Solid/GGO/mixed   WR                         Med 11: (1 to 108) NED
  Kataoka[^7^](#pin12904-bib-0007){ref-type="ref"} 2018    58F                     N/A        11                 N/A               Lobectomy                  21 NED
                                                           69F                     N/A        4                  N/A               PR                         51 NED
                                                           71M                     N/A        5                  N/A               PR                         17 NED
                                                           66M                     N/A        6                  N/A               PR                         36 NED
  Miyai[^8^](#pin12904-bib-0008){ref-type="ref"} 2018      67F                     RML        18                 Nodule            WR                         4 NED
  Mikubo[^9^](#pin12904-bib-0009){ref-type="ref"} 2019     69M                     LLL        12                 Nodule            WR                         8 NED
  Shao[^3^](#pin12904-bib-0003){ref-type="ref"} 2019       58F                     LLL        8                  GGO               WR                         N/A
                                                           66F                     RLL        6                  Nodule            WR                         N/A
  Shen[^10^](#pin12904-bib-0010){ref-type="ref"} 2019      58M                     RLL        11                 Nodule            WR                         N/A
                                                           64F                     LLL        8.5                Nodule            WR                         N/A

Abbreviations: Ave, average; GGO, ground‐glass opacity; LLL, left lower lobe; LUL, left upper lobe; Med, median; N/A, not applicable; NED, no evidence of disease; NWC, nodule with cavity; PR, partial resection; RUL, right upper lobe; RML, right middle lobe; WR, wedge resection.
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Bronchiolar adenoma seems to be an indolent tumor with a very good prognosis, leading some investigators to question whether it is a reactive or hamartomatous lesion. However, the very recent molecular study of BA has identified *BRAF* V600E mutations (38%), unusual *EGFR* exon 19 deletions (10%), *EGFR* exon 20 insertions (10%), *Kirsten‐RAS* mutations (24%), and *Harvey‐RAS* mutations (5%), supporting a truly neoplastic process of BA.[^2^](#pin12904-bib-0002){ref-type="ref"} In the present case, however, no gene mutations were identified.

The gene promotor methylation of tumor suppressor p16^INK4a^ (often simply referred to p16) has also been detected in non‐small cell lung carcinoma (NSCLC), leading to loss of expression of p16^INK4a^ protein.[^11^](#pin12904-bib-0011){ref-type="ref"} Together with the key tumor suppressors P14ARF and P15INK4b, p16^INK4a^ is encoded by the *INK4/ARF* locus, one of the most affected genomic regions in human cancer cells.[^11^](#pin12904-bib-0011){ref-type="ref"}, [^12^](#pin12904-bib-0012){ref-type="ref"} Zhou *et al*.[^12^](#pin12904-bib-0012){ref-type="ref"} investigated the aberrant expression of p16^INK4a^ in primary NSCLC. They found that p16^INK4a^ was detected in 50.7% of adenocarcinomas and 35.2% of squamous cell carcinomas. In adenocarcinoma of the lung, p16^INK4a^‐positive lesions accompanied a favorable clinical outcome, when compared with p16^INK4a^‐negative tumors. Kim *et al*.[^6^](#pin12904-bib-0006){ref-type="ref"} reported a case of BA harboring *BRAF* V600E mutation and p16^INK4a^ overexpression without evidence of HPV infection. They proposed a concept of oncogene‐induced senescence (OIS). The present case also showed overexpression of p16^INK4a^ unrelated to HPV infection.

*BRAF* V600E mutation is frequently found in various benign tumors. Most melanocytic nevi and a subset of colonic serrated polyps/adenomas show the mutation.[^6^](#pin12904-bib-0006){ref-type="ref"} Mutation of oncogenic *BRAF* induces proliferation of melanocytes and crypt epithelial cells, leading to formation of a tumorous mass. However, most of them do not show continuous proliferation or progress to malignant tumors. Nevi and hyperplastic crypts remain dormant for a long period of time with low proliferative activity. Similarly, accelerated expression of p16^INK4a^ provokes senescence‐associated acidic‐β‐galactosidase activity, namely representing OIS.[^6^](#pin12904-bib-0006){ref-type="ref"} Reportedly, mixed squamous cell and glandular papilloma of the lung expresses p16^INK4a^.[^13^](#pin12904-bib-0013){ref-type="ref"} In the present case, BA showed the aberrant overexpression of p16^INK4a^. p16^INK4a^ may function as one of the favorable prognostic markers in pulmonary glandular neoplasms.

We present for the first‐time ultrastructural findings of BA. The bronchiolar epithelial tubules consisted of two layers; the inner nonciliated microvillous luminal cells and outer basal cells. Some of the luminal cells were filled with mucin granules in the cytoplasm. The cytoplasm of the basal cells was scanty. Wu *et al*.[^14^](#pin12904-bib-0014){ref-type="ref"} reported p63 immunoreactivity in both precursor lesions and adenocarcinoma *in situ*, and the p63‐positive cells belonged to atypical epithelial cells. p63 was negative in well‐differentiated adenocarcinoma: namely, the malignant neoplastic lesions contained no basal cells. For the differential diagnosis of BA and malignancy, not only immunohistochemical study but also ultrastructural analysis must be useful.

The present lesion was misdiagnosed as adenocarcinoma in the intraoperative frozen section diagnosis. The frozen sections showed central glandular growth with peripheral spreading of mucin‐containing columnar cells along the alveolar wall. Close observation of the permanent slides exhibited that the tumor was consistently composed of ciliated and nonciliated mucous columnar cells and basal cells. The presence of basal cells was confirmed by immunostaining for CK5/6, p40, p63 and podoplanin afterwards. Pathologists must be aware of the possibility of BA, particularly in the setting of frozen section diagnosis.

A similar benign lesion named peribronchiolar metaplasia should additionally be discussed. Peribronchiolar metaplasia represents a small airway lesion consisting of ciliate, columnar and mucinous cells often accompanying a mucin lake, and is usually associated with interstitial lung disorders. This reactive lesion typically appears as multiple fibrotic nodules around growing ciliated bronchiolar cells as a process of airway‐centered (centrilobular) interstitial fibrosis.[^15^](#pin12904-bib-0015){ref-type="ref"} The lung lesion in the present case was solitary without interstitial changes, to be distinguished from peribronchiolar metaplasia.

In conclusion, despite its rarity, BA should be considered when cytological, histological, immunohistochemical or electron microscopic evaluations of a solitary peripheral lung nodule reveal nonatypical ciliated or nonciliated mucous cells surrounded by secreted mucin. It is expected that computed tomography image analysis should accelerate the detection of a small mucinous lung lesion. Further data collection is required for clarifying the radio‐clinicopathological characteristics of BA.
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